Amy Marie Meyer - Publications

Affiliations: 
2003 University of Colorado Anschutz Medical Campus, Denver, Aurora, CO 

14 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2008 Nemenoff R, Meyer AM, Hudish TM, Mozer AB, Snee A, Narumiya S, Stearman RS, Winn RA, Weiser-Evans M, Geraci MW, Keith RL. Prostacyclin prevents murine lung cancer independent of the membrane receptor by activation of peroxisomal proliferator--activated receptor gamma. Cancer Prevention Research (Philadelphia, Pa.). 1: 349-56. PMID 19138979 DOI: 10.1158/1940-6207.Capr-08-0145  0.681
2008 Bren-Mattison Y, Meyer AM, Van Putten V, Li H, Kuhn K, Stearman R, Weiser-Evans M, Winn RA, Heasley LE, Nemenoff RA. Antitumorigenic effects of peroxisome proliferator-activated receptor-gamma in non-small-cell lung cancer cells are mediated by suppression of cyclooxygenase-2 via inhibition of nuclear factor-kappaB. Molecular Pharmacology. 73: 709-17. PMID 18055759 DOI: 10.1124/Mol.107.042002  0.566
2006 Keith RL, Geraci MW, Nana-Sinkam SP, Breyer RM, Hudish TM, Meyer AM, Malkinson AM, Dwyer-Nield LD. Prostaglandin E2 receptor subtype 2 (EP2) null mice are protected against murine lung tumorigenesis. Anticancer Research. 26: 2857-61. PMID 16886605  0.719
2006 Meyer AM, Dwyer-Nield LD, Hurteau G, Keith RL, Ouyang Y, Freed BM, Kisley LR, Geraci MW, Bonventre JV, Nemenoff RA, Malkinson AM. Attenuation of the pulmonary inflammatory response following butylated hydroxytoluene treatment of cytosolic phospholipase A2 null mice. American Journal of Physiology. Lung Cellular and Molecular Physiology. 290: L1260-6. PMID 16443645 DOI: 10.1152/Ajplung.00182.2005  0.66
2005 Dwyer-Nield LD, Srebernak MC, Barrett BS, Ahn J, Cosper P, Meyer AM, Kisley LR, Bauer AK, Thompson DC, Malkinson AM. Cytokines differentially regulate the synthesis of prostanoid and nitric oxide mediators in tumorigenic versus non-tumorigenic mouse lung epithelial cell lines. Carcinogenesis. 26: 1196-206. PMID 15746162 DOI: 10.1093/Carcin/Bgi061  0.73
2005 Blaine SA, Meyer AM, Hurteau G, Wick M, Hankin JA, Murphy RC, Dannenberg AJ, Geraci MW, Subbaramaiah K, Nemenoff RA. Targeted over-expression of mPGES-1 and elevated PGE2 production is not sufficient for lung tumorigenesis in mice. Carcinogenesis. 26: 209-17. PMID 15471895 DOI: 10.1093/Carcin/Bgh302  0.652
2004 Zerbe LK, Pino I, Pio R, Cosper PF, Dwyer-Nield LD, Meyer AM, Port JD, Montuenga LM, Malkinson AM. Relative amounts of antagonistic splicing factors, hnRNP A1 and ASF/SF2, change during neoplastic lung growth: implications for pre-mRNA processing. Molecular Carcinogenesis. 41: 187-96. PMID 15390079 DOI: 10.1002/Mc.20053  0.662
2004 Zhang F, Pao W, Umphress S, Jakowlew S, Meyer AM, Dwyer-Nield LD, Takeda K, Gelfand EW, Fisher J, Malkinson AM, Mason RJ. Serum levels of surfactant protein D are increased in mice with lung tumors. Chest. 125: 109S. PMID 15136449  0.722
2004 Meyer AM, Dwyer-Nield LD, Hurteau GJ, Keith RL, O'Leary E, You M, Bonventre JV, Nemenoff RA, Malkinson AM. Decreased lung tumorigenesis in mice genetically deficient in cytosolic phospholipase A2. Carcinogenesis. 25: 1517-24. PMID 15033900 DOI: 10.1093/Carcin/Bgh150  0.762
2004 Zhang F, Pao W, Umphress S, Jakowlew S, Meyer A, Dwyer-Nield L, Takeda K, Gelfand E, Fisher J, Malkinson A, Mason RJ. Serum Levels of Surfactant Protein D Are Increased in Mice With Lung Tumors Chest. 125: 109S. DOI: 10.1378/Chest.125.5_Suppl.109S-A  0.719
2003 Zhang F, Pao W, Umphress SM, Jakowlew SB, Meyer AM, Dwyer-Nield LD, Nielsen LD, Takeda K, Gelfand EW, Fisher JH, Zhang L, Malkinson AM, Mason RJ. Serum levels of surfactant protein D are increased in mice with lung tumors. Cancer Research. 63: 5889-94. PMID 14522914  0.709
2003 Zhang F, Pao W, Umphress S, Jackowlew S, Meyer AM, Dwyer-Nield L, Malkinson AM, Mason RJ. P-640 Serum levels of surfactant protein D are increased in mice with lung tumors Lung Cancer. 41. DOI: 10.1016/S0169-5002(03)92607-9  0.721
2002 Kisley LR, Barrett BS, Bauer AK, Dwyer-Nield LD, Barthel B, Meyer AM, Thompson DC, Malkinson AM. Genetic ablation of inducible nitric oxide synthase decreases mouse lung tumorigenesis. Cancer Research. 62: 6850-6. PMID 12460898  0.762
2000 Malkinson AM, Bauer A, Meyer A, Dwyer-Nield L, Koski K, Keith R, Geraci M, Miller Y-. Experimental Evidence From an Animal Model of Adenocarcinoma That Chronic Inflammation Enhances Lung Cancer Risk Chest. 117: 228. PMID 10843922 DOI: 10.1378/Chest.117.5_Suppl_1.228S  0.691
Show low-probability matches.